Alessandra Maccabeo
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Alessandra Maccabeo has a total of 43 co-authors. Here are the top co-authors by number of shared publications:
- Adriano Chiò
‘Rita Levi Montalcini’ Department of Neuroscience University of Torino Torino Italy
4 shared publications - Andrea Calvo
‘Rita Levi Montalcini’ Department of Neuroscience University of Torino Torino Italy
4 shared publications - Antonio Canosa
Rita Levi Montalcini Department of Neuroscience University of Turin Turin Italy
4 shared publications - Cristina Moglia
ALS Center, ‘Rita Levi Montalcini’ Department of Neuroscience, University of Turin, Turin, Italy
4 shared publications - Francesca Palumbo
“Rita Levi Montalcini” Department of Neuroscience, University of Turin
4 shared publications - Giorgio Pellegrino
‘Rita Levi Montalcini’ Department of Neuroscience University of Torino Torino Italy
4 shared publications
Latest Publications
- Open Access
- 19 October 2026
- Published by Taylor & Francis in Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration
- p. 1-10
Factors associated with post-tracheostomy survival in Amyotrophic Lateral Sclerosis
Amyotrophic Lateral Sclerosis (ALS) is a rare neurodegenerative disease characterized by upper and lower motor neuron degeneration. It leads to progressive muscle paralysis and ultimately results i...
- 19 October 2026
- Published by Taylor & Francis in Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration
- p. 1-10
Open AccessFactors associated with post-tracheostomy survival in Amyotrophic Lateral Sclerosis
Amyotrophic Lateral Sclerosis (ALS) is a rare neurodegenerative disease characterized by upper and lower motor neuron degeneration. It leads to progressive muscle paralysis and ultimately results i...
- Open Access
- 7 October 2026
- Published by Wiley in European Journal of Neurology
- Vol. 33 (10) , e70778
Recalibration of the Frontal Behavioural Inventory Cut‐Off for Behavioural Screening in Amyotrophic Lateral Sclerosis
Objective: The Frontal Behavioural Inventory (FBI) was validated in behavioural‐variant frontotemporal dementia (bvFTD) with a cut‐off of 25. We tested whether this threshold is appropriate in amyotrophic lateral sclerosis (ALS), where behavioural change is milder and partly confounded by motor pathology. Methods: We analysed 506 ALS patients with a valid FBI assessment. Behavioural impairment was defined using two complementary reference standards, to minimise dependence on any single behavioural instrument: a consensus rule (pathology on ≥ 2 of three independent instruments: Edinburgh Cognitive and Behavioural ALS Screen, Frontal Systems Behaviour Scale, Beaumont Behavioural Inventory) and Latent Class Analysis. ROC analysis identified the Youden‐optimal cut‐off; agreement was quantified by Cohen's κ ; internal validity was assessed by stratified 5‐fold cross‐validation. Total and subscale scores were analysed separately. Results: Among 345 complete‐case patients, 24.6% met criteria for behavioural impairment. The FBI total discriminated impairment well (AUC 0.855, 95% CI 0.806–0.898). The Youden‐optimal cut‐off was FBI ≥ 9 (sensitivity 0.87, specificity 0.74), whereas the legacy cut‐off of 25 showed sensitivity 0.22. Subscale recalibration yielded cut‐offs of FBI‐Apathy ≥ 7 (AUC 0.808) and FBI‐Disinhibition ≥ 4 (AUC 0.851). Conclusions: In ALS, the bvFTD‐derived threshold of 25 misses most patients with behavioural involvement. FBI ≥ 9 is a promising candidate ALS‐specific screening threshold, with scores ≥ 15 indicating a higher probability of behavioural involvement; exploratory subscale thresholds of ≥ 7 for Apathy and ≥ 4 for Disinhibition are also proposed. These cut‐offs substantially improve sensitivity while maintaining acceptable specificity, but require prospective external validation before replacing current practice.
- 7 October 2026
- Published by Wiley in European Journal of Neurology
- Vol. 33 (10) , e70778
Open AccessRecalibration of the Frontal Behavioural Inventory Cut‐Off for Behavioural Screening in Amyotrophic Lateral Sclerosis
Objective: The Frontal Behavioural Inventory (FBI) was validated in behavioural‐variant frontotemporal dementia (bvFTD) with a cut‐off of 25. We tested whether this threshold is appropriate in amyotrophic lateral sclerosis (ALS), where behavioural change is milder and partly confounded by motor pathology. Methods: We analysed 506 ALS patients with a valid FBI assessment. Behavioural impairment was defined using two complementary reference standards, to minimise dependence on any single behavioural instrument: a consensus rule (pathology on ≥ 2 of three independent instruments: Edinburgh Cognitive and Behavioural ALS Screen, Frontal Systems Behaviour Scale, Beaumont Behavioural Inventory) and Latent Class Analysis. ROC analysis identified the Youden‐optimal cut‐off; agreement was quantified by Cohen's κ ; internal validity was assessed by stratified 5‐fold cross‐validation. Total and subscale scores were analysed separately. Results: Among 345 complete‐case patients, 24.6% met criteria for behavioural impairment. The FBI total discriminated impairment well (AUC 0.855, 95% CI 0.806–0.898). The Youden‐optimal cut‐off was FBI ≥ 9 (sensitivity 0.87, specificity 0.74), whereas the legacy cut‐off of 25 showed sensitivity 0.22. Subscale recalibration yielded cut‐offs of FBI‐Apathy ≥ 7 (AUC 0.808) and FBI‐Disinhibition ≥ 4 (AUC 0.851). Conclusions: In ALS, the bvFTD‐derived threshold of 25 misses most patients with behavioural involvement. FBI ≥ 9 is a promising candidate ALS‐specific screening threshold, with scores ≥ 15 indicating a higher probability of behavioural involvement; exploratory subscale thresholds of ≥ 7 for Apathy and ≥ 4 for Disinhibition are also proposed. These cut‐offs substantially improve sensitivity while maintaining acceptable specificity, but require prospective external validation before replacing current practice.
- Open Access
- 18 September 2026
- Published by Springer Nature in Journal of Neurology
- Vol. 273 (10) , 604
What do ALS motor phenotypes measure? A population-based decomposition of their prognostic dimensions
Background: The ALS-OPM 3.3 classification stratifies incident ALS through three axes: onset region (O), propagation time (P) and motor-neuron pattern (M). We assessed whether OPM 3.3 improves prognostic discrimination over established classifications and characterised how it decomposes their prognostic signal in a population-based cohort. Methods: In the prospective Piedmont and Aosta Valley ALS Register (2000–2022), patients were classified on the three axes; M was operationalised as M_3class (M0 balanced, M1d UMN-predominant, M2d LMN-predominant), with the PLS-spectrum M1p analysed separately. Outcome was survival (death or tracheostomy) from onset. Multivariable Cox models (O, P1(n), M_3class, age, sex) underwent bootstrap optimism-correction and fivefold cross-validation, and were compared against alternative taxonomies and clinical staging systems. Results: Amongst 2,738 non-PLS patients (2,561 events, 93.5%), median survival differed across M classes (M0 27.0, M2d 36.0, M1d 41.9 months). OPM 3.3 outperformed the bulbar/spinal dichotomy but matched the classical phenotype (optimism-corrected C-index 0.703, 95% CI 0.685–0.719 vs 0.701). In the arm-proximal cell (95.7% M2d), the O2p protective effect vanished after M adjustment (HR 0.99, 95% CI 0.79–1.24), whilst M2d retained HR 0.83 (95% CI 0.72–0.95), showing prognosis reflects motor-neuron pattern, not anatomy. Adding King’s, Milano-Torino (MiToS), or Fine’til 9 (FT9) clinical staging further improved discrimination. Conclusions: OPM 3.3 did not improve discrimination over established phenotypes but decomposed their prognostic signal into independently interpretable dimensions. Favourable prognosis of arm-proximal/flail-arm onset reflects the underlying LMN-predominant phenotype, not onset site. The motor-neuron axis is robust to the treatment of the propagation axis and independent of clinical staging.
- 18 September 2026
- Published by Springer Nature in Journal of Neurology
- Vol. 273 (10) , 604
Open AccessWhat do ALS motor phenotypes measure? A population-based decomposition of their prognostic dimensions
Background: The ALS-OPM 3.3 classification stratifies incident ALS through three axes: onset region (O), propagation time (P) and motor-neuron pattern (M). We assessed whether OPM 3.3 improves prognostic discrimination over established classifications and characterised how it decomposes their prognostic signal in a population-based cohort. Methods: In the prospective Piedmont and Aosta Valley ALS Register (2000–2022), patients were classified on the three axes; M was operationalised as M_3class (M0 balanced, M1d UMN-predominant, M2d LMN-predominant), with the PLS-spectrum M1p analysed separately. Outcome was survival (death or tracheostomy) from onset. Multivariable Cox models (O, P1(n), M_3class, age, sex) underwent bootstrap optimism-correction and fivefold cross-validation, and were compared against alternative taxonomies and clinical staging systems. Results: Amongst 2,738 non-PLS patients (2,561 events, 93.5%), median survival differed across M classes (M0 27.0, M2d 36.0, M1d 41.9 months). OPM 3.3 outperformed the bulbar/spinal dichotomy but matched the classical phenotype (optimism-corrected C-index 0.703, 95% CI 0.685–0.719 vs 0.701). In the arm-proximal cell (95.7% M2d), the O2p protective effect vanished after M adjustment (HR 0.99, 95% CI 0.79–1.24), whilst M2d retained HR 0.83 (95% CI 0.72–0.95), showing prognosis reflects motor-neuron pattern, not anatomy. Adding King’s, Milano-Torino (MiToS), or Fine’til 9 (FT9) clinical staging further improved discrimination. Conclusions: OPM 3.3 did not improve discrimination over established phenotypes but decomposed their prognostic signal into independently interpretable dimensions. Favourable prognosis of arm-proximal/flail-arm onset reflects the underlying LMN-predominant phenotype, not onset site. The motor-neuron axis is robust to the treatment of the propagation axis and independent of clinical staging.
- Open Access
- 31 July 2026
- Published by Wiley in European Journal of Neurology
- Vol. 33 (8) , e70720
Early Cognitive and Behavioral Changes in Primary Lateral Sclerosis: A Population‐Based Study
Objective: Primary lateral sclerosis (PLS) is a rare upper motor neuron neurodegenerative disorder whose cognitive profile, particularly at early stages, remains incompletely defined. We aimed to characterize cognitive and behavioral features of PLS at diagnosis and compare them with predominant upper motor neuron amyotrophic lateral sclerosis (PUMN‐ALS) and healthy controls (HCs). Methods: Patients diagnosed with PLS between 2007 and 2021 were identified from the population‐based Piemonte and Valle d'Aosta ALS Register. Diagnoses were established according to consensus criteria, including early, probable, and definite PLS. All patients underwent comprehensive neuropsychological and behavioral assessment within 3 months of their first ALS center visit. Cognitive–behavioral status was classified using ALS–frontotemporal dementia (FTD) consensus criteria. Results: Thirty‐two PLS patients were included (mean disease duration, 25 months). Cognitive and/or behavioral impairment was identified in 29.3% of patients, most commonly affecting executive function, memory, and social cognition, including 21.1% early PLS. Compared with HCs, PLS patients showed poorer performance across several cognitive domains and higher anxiety and depression scores. Compared with matched PUMN‐ALS patients, PLS patients demonstrated slightly worse executive performance, while the overall frequency of cognitive–behavioral impairment was similar. Behavioral profiles differed qualitatively, with apathy more frequent in PUMN‐ALS. No PLS patient met criteria for frontotemporal dementia. Interpretation: Cognitive and behavioral impairments are already detectable at the time of diagnosis in a substantial proportion of patients with PLS, including early PLS, supporting the view of PLS as a multidimensional neurodegenerative disorder with early extramotor involvement.
- 31 July 2026
- Published by Wiley in European Journal of Neurology
- Vol. 33 (8) , e70720
Open AccessEarly Cognitive and Behavioral Changes in Primary Lateral Sclerosis: A Population‐Based Study
Objective: Primary lateral sclerosis (PLS) is a rare upper motor neuron neurodegenerative disorder whose cognitive profile, particularly at early stages, remains incompletely defined. We aimed to characterize cognitive and behavioral features of PLS at diagnosis and compare them with predominant upper motor neuron amyotrophic lateral sclerosis (PUMN‐ALS) and healthy controls (HCs). Methods: Patients diagnosed with PLS between 2007 and 2021 were identified from the population‐based Piemonte and Valle d'Aosta ALS Register. Diagnoses were established according to consensus criteria, including early, probable, and definite PLS. All patients underwent comprehensive neuropsychological and behavioral assessment within 3 months of their first ALS center visit. Cognitive–behavioral status was classified using ALS–frontotemporal dementia (FTD) consensus criteria. Results: Thirty‐two PLS patients were included (mean disease duration, 25 months). Cognitive and/or behavioral impairment was identified in 29.3% of patients, most commonly affecting executive function, memory, and social cognition, including 21.1% early PLS. Compared with HCs, PLS patients showed poorer performance across several cognitive domains and higher anxiety and depression scores. Compared with matched PUMN‐ALS patients, PLS patients demonstrated slightly worse executive performance, while the overall frequency of cognitive–behavioral impairment was similar. Behavioral profiles differed qualitatively, with apathy more frequent in PUMN‐ALS. No PLS patient met criteria for frontotemporal dementia. Interpretation: Cognitive and behavioral impairments are already detectable at the time of diagnosis in a substantial proportion of patients with PLS, including early PLS, supporting the view of PLS as a multidimensional neurodegenerative disorder with early extramotor involvement.
- Open Access
- 10 September 2024
- Published by Springer Nature in Journal of Neurology
- Vol. 271 (12) , 7489-7493
Takotsubo syndrome in a Sardinian amyotrophic lateral sclerosis cohort
Introduction: Amyotrophic lateral sclerosis (ALS) is known to be associated with varying degrees of autonomic and cardiovascular dysfunction. Recent case reports showed that ALS may be linked to Takotsubo syndrome (TTS). We assessed the frequency of TTS in an incident ALS cohort from Sardinia, Italy, and investigated the relationship of TTS with ALS course. Methods: We retrospectively examined a 10-year (2010–2019) incident cohort of ALS patients of Sardinian ancestry, reported TTS frequency and patients’ clinical characteristics. Following, we checked for TTS among patients with ALS onset after 2019 and focused on the same features as for the incident cohort. Results: Our incident cohort included 344 ALS patients and 5 of them (1.45%) developed TTS. All were female and their median onset age was 71.5 years (IQR 62.75–77). Two patients had spinal and three bulbar onset, though all patients had bulbar involvement and were at an advanced stage of disease (ALSFRS ≤ 25, King’s ≥ 3) at TTS diagnosis. We identified a potential TTS trigger in three patients (hospitalization for PEG placement, pneumonia). Among patients who had ALS onset after 2019, we identified a further TTS case and described it. Conclusion: TTS is not a rare condition in ALS. Female sex, bulbar involvement, and later age of disease onset may be important risk factors for developing this cardiac condition and a physical or psychological trigger is often observed. Despite autonomic dysfunction in ALS has been already demonstrated, the precise physiopathological mechanism underlying TTS needs to be further clarified.
- 10 September 2024
- Published by Springer Nature in Journal of Neurology
- Vol. 271 (12) , 7489-7493
Open AccessTakotsubo syndrome in a Sardinian amyotrophic lateral sclerosis cohort
Introduction: Amyotrophic lateral sclerosis (ALS) is known to be associated with varying degrees of autonomic and cardiovascular dysfunction. Recent case reports showed that ALS may be linked to Takotsubo syndrome (TTS). We assessed the frequency of TTS in an incident ALS cohort from Sardinia, Italy, and investigated the relationship of TTS with ALS course. Methods: We retrospectively examined a 10-year (2010–2019) incident cohort of ALS patients of Sardinian ancestry, reported TTS frequency and patients’ clinical characteristics. Following, we checked for TTS among patients with ALS onset after 2019 and focused on the same features as for the incident cohort. Results: Our incident cohort included 344 ALS patients and 5 of them (1.45%) developed TTS. All were female and their median onset age was 71.5 years (IQR 62.75–77). Two patients had spinal and three bulbar onset, though all patients had bulbar involvement and were at an advanced stage of disease (ALSFRS ≤ 25, King’s ≥ 3) at TTS diagnosis. We identified a potential TTS trigger in three patients (hospitalization for PEG placement, pneumonia). Among patients who had ALS onset after 2019, we identified a further TTS case and described it. Conclusion: TTS is not a rare condition in ALS. Female sex, bulbar involvement, and later age of disease onset may be important risk factors for developing this cardiac condition and a physical or psychological trigger is often observed. Despite autonomic dysfunction in ALS has been already demonstrated, the precise physiopathological mechanism underlying TTS needs to be further clarified.